IT1284604B1 - Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva - Google Patents

Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva

Info

Publication number
IT1284604B1
IT1284604B1 IT96MI001983A ITMI961983A IT1284604B1 IT 1284604 B1 IT1284604 B1 IT 1284604B1 IT 96MI001983 A IT96MI001983 A IT 96MI001983A IT MI961983 A ITMI961983 A IT MI961983A IT 1284604 B1 IT1284604 B1 IT 1284604B1
Authority
IT
Italy
Prior art keywords
controlled release
oral administration
pharmaceutical compositions
release pharmaceutical
active substance
Prior art date
Application number
IT96MI001983A
Other languages
English (en)
Inventor
Roberto Valducci
Original Assignee
Roberto Valducci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Valducci filed Critical Roberto Valducci
Priority to IT96MI001983A priority Critical patent/IT1284604B1/it
Priority to US08/925,966 priority patent/US5871775A/en
Priority to ZA9708099A priority patent/ZA978099B/xx
Priority to AU37567/97A priority patent/AU719075B2/en
Priority to DE69723024T priority patent/DE69723024T2/de
Priority to EP97116153A priority patent/EP0838218B1/en
Priority to AT97116153T priority patent/ATE243499T1/de
Priority to ES97116153T priority patent/ES2202528T3/es
Priority to NZ328783A priority patent/NZ328783A/en
Priority to CA002216277A priority patent/CA2216277C/en
Priority to CN97119609A priority patent/CN1110304C/zh
Priority to BR9706214A priority patent/BR9706214A/pt
Priority to JP9263279A priority patent/JPH10152440A/ja
Publication of ITMI961983A1 publication Critical patent/ITMI961983A1/it
Application granted granted Critical
Publication of IT1284604B1 publication Critical patent/IT1284604B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
IT96MI001983A 1996-09-27 1996-09-27 Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva IT1284604B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT96MI001983A IT1284604B1 (it) 1996-09-27 1996-09-27 Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US08/925,966 US5871775A (en) 1996-09-27 1997-09-09 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
ZA9708099A ZA978099B (en) 1996-09-27 1997-09-09 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance.
AU37567/97A AU719075B2 (en) 1996-09-27 1997-09-12 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
EP97116153A EP0838218B1 (en) 1996-09-27 1997-09-17 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
AT97116153T ATE243499T1 (de) 1996-09-27 1997-09-17 Pharmazeutische zusammensetzungen mit kontrollierter freisetzung zur oralen verabreichung enthaltend nifedipin als wirkstoff
DE69723024T DE69723024T2 (de) 1996-09-27 1997-09-17 Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
ES97116153T ES2202528T3 (es) 1996-09-27 1997-09-17 Composiciones farmaceuticas de liberacion controlada para la administracion oral que contienen nifedipina como principio activo.
NZ328783A NZ328783A (en) 1996-09-27 1997-09-18 Sustained release composition containing nifedipine and polyvinyl pyrrolidine
CA002216277A CA2216277C (en) 1996-09-27 1997-09-22 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
CN97119609A CN1110304C (zh) 1996-09-27 1997-09-26 用于口服的含有活性成份硝苯吡啶的缓释药物组合物
BR9706214A BR9706214A (pt) 1996-09-27 1997-09-26 Composições farmacêuticas de liberação controlada para administração oral contendo nifedipina como substância ativa e processo para a preparação de composiç es farmacêuticas para a administração oral contendo nifedipina como substância ativa
JP9263279A JPH10152440A (ja) 1996-09-27 1997-09-29 活性物質としてニフェジピンを含有する経口投与用調節放出医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001983A IT1284604B1 (it) 1996-09-27 1996-09-27 Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva

Publications (2)

Publication Number Publication Date
ITMI961983A1 ITMI961983A1 (it) 1998-03-27
IT1284604B1 true IT1284604B1 (it) 1998-05-21

Family

ID=11374935

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001983A IT1284604B1 (it) 1996-09-27 1996-09-27 Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva

Country Status (13)

Country Link
US (1) US5871775A (it)
EP (1) EP0838218B1 (it)
JP (1) JPH10152440A (it)
CN (1) CN1110304C (it)
AT (1) ATE243499T1 (it)
AU (1) AU719075B2 (it)
BR (1) BR9706214A (it)
CA (1) CA2216277C (it)
DE (1) DE69723024T2 (it)
ES (1) ES2202528T3 (it)
IT (1) IT1284604B1 (it)
NZ (1) NZ328783A (it)
ZA (1) ZA978099B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
WO2006066932A1 (en) * 2004-12-24 2006-06-29 Lek Pharmaceuticals D.D. Stable pharmaceutical composition comprising an active substance in the form of solid solution
EP1912730A2 (en) * 2005-07-28 2008-04-23 Isp Investments Inc. Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
WO2008080037A2 (en) * 2006-12-21 2008-07-03 Isp Investments Inc. Carotenoids of enhanced bioavailability
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
JP5508859B2 (ja) * 2007-01-26 2014-06-04 アイエスピー インヴェストメンツ インコーポレイテッド 噴霧乾燥製品を製造するための調剤処理方法
DE102007048705A1 (de) 2007-10-11 2009-04-16 Bayer Healthcare Ag Amorphe Formulierung
WO2014016842A1 (en) * 2012-07-23 2014-01-30 Symed Labs Limited Amorphous coprecipitates of rivaroxaban
WO2015051336A1 (en) 2013-10-03 2015-04-09 David Wise Compositions and methods for treating pelvic pain and other conditions
CN109730967B (zh) * 2019-02-19 2021-08-03 广东工业大学 一种硝苯地平固体分散体及其制备方法
CN115844845B (zh) * 2022-08-29 2025-03-14 迪沙药业集团有限公司 一种硝苯地平缓释制剂及制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
EP0143857B1 (de) * 1983-11-30 1988-04-06 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
JPS6136213A (ja) * 1984-07-27 1986-02-20 Rooto Seiyaku Kk 口腔用組成物
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
CN1120435A (zh) * 1994-01-04 1996-04-17 贵州泰康中医保健技术有限公司 硝苯吡啶缓释胶囊
CN1129103A (zh) * 1995-02-14 1996-08-21 永信药品工业股份有限公司 硝苯吡啶剂型的开发
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung
SI9500173B (sl) * 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo

Also Published As

Publication number Publication date
CA2216277C (en) 2003-06-10
EP0838218B1 (en) 2003-06-25
ES2202528T3 (es) 2004-04-01
CN1183960A (zh) 1998-06-10
DE69723024D1 (de) 2003-07-31
BR9706214A (pt) 1999-05-04
US5871775A (en) 1999-02-16
ATE243499T1 (de) 2003-07-15
CA2216277A1 (en) 1998-03-27
NZ328783A (en) 1998-02-26
ZA978099B (en) 1998-03-27
AU719075B2 (en) 2000-05-04
AU3756797A (en) 1998-04-02
EP0838218A1 (en) 1998-04-29
DE69723024T2 (de) 2004-04-29
JPH10152440A (ja) 1998-06-09
CN1110304C (zh) 2003-06-04
ITMI961983A1 (it) 1998-03-27

Similar Documents

Publication Publication Date Title
TW355683B (en) Composition containing micronized nebivolol
ZA978099B (en) Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance.
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
NO20016107D0 (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
SE8804629D0 (sv) New therapeutically active compounds
ATE207345T1 (de) ORALE METOPROLOL-DOSISFORM DES TYPS ßEINMAL TÄGLICHß
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
CA2326222A1 (en) Medicinal compositions
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
SE8804628D0 (sv) New compounds
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
KR890701087A (ko) 부스피론 및 그의 염의 경구 투여용 제제
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
EP0535250A4 (en) Novel compounds and use thereof as medicine
DE69300296D1 (de) Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
AU3542697A (en) Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate
BE880648A (fr) Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation
ATE335491T1 (de) Arzneimittel gegen glomerulosclerose
IL122719A0 (en) Controlled release pharmaceutical compositions for oral administration containing nifedipine as active substance

Legal Events

Date Code Title Description
0001 Granted